Michal Lotem
- Oncology top 0.5%
- Molecular Biology top 5%
- Immunology top 1%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Co-authors
- Jacob SchachterAntoni RibasGeorgina V. LongNageatte IbrahimCatriona M. McNeilAdil DaudOmid HamidAna Arance
- Topics
- Immunotherapy and Immune Responses (39 papers)Cancer Immunotherapy and Biomarkers (39 papers)CAR-T cell therapy research (37 papers)
- Cited by
- OncologyImmunologyMolecular Biology
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Michal Lotem
102 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 3.4k
- Molecular Biology 1.9k
- Immunology 1.8k
- Pulmonary and Respiratory Medicine 555
- Cancer Research 308
Countries citing papers authored by Michal Lotem
This map shows the geographic impact of Michal Lotem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Lotem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Lotem more than expected).
Fields of papers citing papers by Michal Lotem
This network shows the impact of papers produced by Michal Lotem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Lotem. The network helps show where Michal Lotem may publish in the future.
Co-authorship network of co-authors of Michal Lotem
This figure shows the co-authorship network connecting the top 25 collaborators of Michal Lotem. A scholar is included among the top collaborators of Michal Lotem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Lotem. Michal Lotem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 38 | |
| 5 | 0 | |
| 6 | 63 | |
| 7 | 1 | |
| 8 | 14 | |
| 9 | 72 | |
| 10 | 111 | |
| 11 | 2 | |
| 12 | 219 | |
| 13 | 19 | |
| 14 | 12 | |
| 15 | 1 | |
| 16 | 27 | |
| 17 | 80 | |
| 18 | 16 | |
| 19 | Post Hepatectomy Survival of Metastatic Uveal Melanoma Patients | 1 |
| 20 | 9 |
About Michal Lotem
Michal Lotem is a scholar working on Oncology, Immunology and Ophthalmology, having authored 106 papers that have together received 4.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (39 papers), Cancer Immunotherapy and Biomarkers (39 papers) and CAR-T cell therapy research (37 papers). The work is most often cited by research in Oncology (3.4k citations), Immunology (1.8k citations) and Molecular Biology (1.9k citations). Michal Lotem has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Jacob Schachter, Antoni Ribas, Georgina V. Long, Nageatte Ibrahim, Catriona M. McNeil, Adil Daud, Omid Hamid, Ana Arance, Matteo S. Carlino and Caroline Robert. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.